Sodium-glucose cotransporter-2 inhibitor in risk of sepsis/septic shock among patients with type 2 diabetes mellitus-a retrospective analysis of nationwide medical claims data.

Hu, Wei-Syun; Lin, Cheng-Li

Hu, Wei-Syun; Lin, Cheng-Li.

Affiliation

Hu WS; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan. weisyunhu@gmail.com.
Lin CL; Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, 2, Yuh-Der Road, Taichung, 40447, Taiwan. weisyunhu@gmail.com.

Naunyn Schmiedebergs Arch Pharmacol ; 397(3): 1623-1631, 2024 03.

Article in En | MEDLINE | ID: mdl-37698621

Subject(s)

Diabetes Complications; Diabetes Mellitus, Type 2; Shock, Septic; Sodium-Glucose Transporter 2 Inhibitors; Humans; Diabetes Mellitus, Type 2/drug therapy; Diabetes Mellitus, Type 2/epidemiology; Sodium-Glucose Transporter 2 Inhibitors/adverse effects; Retrospective Studies; Shock, Septic/drug therapy; Shock, Septic/epidemiology; Shock, Septic/chemically induced; Glucose; Sodium

Key words

Diabetes mellitus; SGLT2I; Sepsis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock, Septic / Diabetes Complications / Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2024 Document type: Article Affiliation country: Taiwan Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google